Lymphedema Arm Clinical Trials

7 recruiting

Lymphedema Arm Trials at a Glance

7 actively recruiting trials for lymphedema arm are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Palo Alto, Maastricht, and Ghent. Lead sponsors running lymphedema arm studies include Maastricht University Medical Center, Dharmais National Cancer Center Hospital, and Koya Medical, Inc..

Browse lymphedema arm trials by phase

Treatments under study

About Lymphedema Arm Clinical Trials

Looking for clinical trials for Lymphedema Arm? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lymphedema Arm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lymphedema Arm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema

Lymphedema ArmLymphedema of Upper LimbLymphedema, Secondary+2 more
Maastricht University Medical Center110 enrolled3 locationsNCT06082349
Recruiting
Not Applicable

Evaluation of Combination Therapy for Upper Extremity Lymphedema

Lymphedema Arm
Stanford University60 enrolled1 locationNCT05825157
Recruiting
Not Applicable

Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer

Lymphedema Arm
Dharmais National Cancer Center Hospital136 enrolled1 locationNCT07233863
Recruiting
Phase 3

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Breast CancerBreast CarcinomaLymphedema+3 more
Memorial Sloan Kettering Cancer Center285 enrolled7 locationsNCT06144164
Recruiting
Not Applicable

The Robot-LVA Study: Robot-assisted Microsurgical Lymphaticovenous Anastomosis in Breast Cancer-related Lymphedema

LymphedemaLymphedema ArmLymphedema of Upper Arm+6 more
Maastricht University Medical Center60 enrolled1 locationNCT06532955
Recruiting
Not Applicable

Added Value of Reconstructive Lymphatic Surgery to Usual Care in Lymphoedema

LymphedemaLymphedema ArmLymphoedema of Leg
Universitaire Ziekenhuizen KU Leuven180 enrolled3 locationsNCT05064176
Recruiting
Not Applicable

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery

LymphedemaLymphedema ArmLymphedema, Breast Cancer
Koya Medical, Inc.20 enrolled1 locationNCT04888975